A meta-analysis published in 2019 concluded that high FGFR2 protein expression in GC was associated with worse outcomes, greater depth of invasion, higher rates of lymph node metastasis, and more advanced disease stage [28]. The gene discussed is FGFR2; the disease is gastric cancer.